The CAD/JPY pair is currently trading within a well-defined descending trendline. Multiple rejections are visible around the 108.300, 105.864, 105.434, and 105.044 levels, confirming strong bearish control over the medium term.
Price has recently bounced from a critical horizontal support near 101.246, forming a short-term bullish move toward the descending trendline. We are now approaching a confluence zone near the 103.800–104.000 area, where the downtrend line intersects. This zone is a potential supply area and could act as a strong resistance.
Trade Idea: Sell Setup Near Trendline (103.800–104.000)
Target: 102.532, 101.250
Invalidation: Break and close above 104.200
Price has recently bounced from a critical horizontal support near 101.246, forming a short-term bullish move toward the descending trendline. We are now approaching a confluence zone near the 103.800–104.000 area, where the downtrend line intersects. This zone is a potential supply area and could act as a strong resistance.
Trade Idea: Sell Setup Near Trendline (103.800–104.000)
Target: 102.532, 101.250
Invalidation: Break and close above 104.200
Trade closed: target reached
We're about to hit 2,000 followers on TradingView! 🚀
Special discount on our pricing plans! 🎉 - t.me/moneydictators
For Premium Research and Elliott wave Guidance: t.me/warlockmd
Special discount on our pricing plans! 🎉 - t.me/moneydictators
For Premium Research and Elliott wave Guidance: t.me/warlockmd
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
We're about to hit 2,000 followers on TradingView! 🚀
Special discount on our pricing plans! 🎉 - t.me/moneydictators
For Premium Research and Elliott wave Guidance: t.me/warlockmd
Special discount on our pricing plans! 🎉 - t.me/moneydictators
For Premium Research and Elliott wave Guidance: t.me/warlockmd
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.